Safety profile Retatrutides most common side effects match what patients experience on semaglutide and tirzepatide: nausea, diarrhea, vomiting, and constipation
Wegovy is FDA-approved to treat obesity, while Ozempic and Rybelsus are approved to treat type 2 diabetes
Lack of funding, however, prevented him from going any further (de Levia, Brugus, de Leiva-Prez
No path to weight loss is complete without an understanding of your body's nutrient needs and how best to meet them
The risk of hypoglycemia may be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogues) or insulin
Most participants found that symptoms improved or resolved as their body adjusted to the medication